Unifrin Multinational Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 223684.94%
- Profit Growth 574.42%
- Ebitda 7258.91%
- Net Worth 753.70%
- Total Assets 6670.27%
About Unifrin Multinational
Unifrin Multinational Private Limited (UMPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 December 2018 (Six years and one month 22 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mani Neelamani and Muthusamy Jayamurugan serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909TN2018PTC126215
- Company No.
126215
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Unifrin Multinational?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthusamy Jayamurugan  | Managing Director | 08-Dec-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mani Neelamani | Director | 08-Dec-2018 | Current |
Financial Performance of Unifrin Multinational.
Unifrin Multinational Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 223684.94% increase. The company also saw a substantial improvement in profitability, with a 574.42% increase in profit. The company's net worth Soared by an impressive increase of 753.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unifrin Multinational?
In 2019, Unifrin Multinational had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novo Health & Hygiene Private LimitedMani Neelamani and Muthusamy Jayamurugan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unifrin Multinational?
Unlock and access historical data on people associated with Unifrin Multinational, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unifrin Multinational, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unifrin Multinational's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.